Evidence map›Paper›PMID 41710831›Full record

ArticleCureus2026

Fluorodeoxyglucose (FDG)-Avid Upper-Lobe Mass Mimicking Malignancy in an Elderly Patient With Allergic Bronchopulmonary Aspergillosis: A Case Report.

Umut Ilhan, Şeyma Özden, Fatma Merve Tepetam, Bahar Aydogar, Erdogan Cetinkaya

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Research trends in COPD-associated invasive pulmonary aspergillosis over the past two decades: a bibliometric and topic modelling analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Umut IlhanPulmonology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, TUR.
Şeyma ÖzdenAllergy and Immunology, University of Health Sciences, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, TUR.
Fatma Merve TepetamAllergy and Immunology, University of Health Sciences, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, TUR.
Bahar AydogarPulmonology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, TUR.
Erdogan CetinkayaPulmonology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic lung disorder that typically occurs in patients with asthma or cystic fibrosis, yet atypical presentations may closely resemble pulmonary malignancy and result in extensive diagnostic evaluation. We report the case of a 75-year-old male with chronic obstructive pulmonary disease (COPD) and long-term wood-dust and mold exposure who presented with fever, progressive cough, purulent sputum, and worsening dyspnea. Chest CT revealed a large heterogeneous mass-like consolidation in the right upper lobe, and PET-CT demonstrated intense fluorodeoxyglucose (FDG) uptake, raising a strong suspicion for lung cancer. Bronchoscopy and biopsy were non-diagnostic. Further evaluation showed peripheral eosinophilia, markedly elevated total IgE, and high

Indexed as

allergic bronchopulmonary aspergillosisaspergillus fumigatus sensitizationfdg avid pulmonary massmass like consolidationpet ct imaging

Identifiers

PMID41710831
PMCPMC12910408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.